PI3K/serine-threonine protein kinase (Akt), a central signaling pathway that regulates neuronal growth and metabolism (Niemarkt et al., 2019), has been widely reported to be involved in cerebral hypoxic-ischemic diseases. The gene discussed is AKT1; the disease is ischemic disease.